Marcos Vinicius Perini

Prof. Marcos Vinicius Perini

Department of Surgery, Austin Health, The University of Melbourne, Melbourne, Victoria, Australia.
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in World Journal of Gastrointestinal Surgery
Verified
Journal Article
Open access
FCFabricio Ferreira Coelho
Fabricio Ferreira Coelho
JKJaime Arthur Pirola Kruger
Jaime Arthur Pirola Kruger
GFGilton Marques Fonseca
Gilton Marques Fonseca
RARaphael Leonardo Cunha Araújo
Raphael Leonardo Cunha Araújo
VJVagner Birk Jeismann
Vagner Birk Jeismann
PHPaulo Herman
Paulo Herman
Laparoscopic liver resection: Experience based guidelines

1 July 2020 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
MPMarcos Vinicius Perini
Marcos Vinicius Perini
RDRhynelle S. Dmello
Rhynelle S. Dmello
TNTracy L. Nero
Tracy L. Nero
ACAshwini Chand
Ashwini Chand

1 August 2013 in Anz Journal of Surgery
Verified
Journal Article
Closed access
PDF file
MNMehrdad Nikfarjam
Mehrdad Nikfarjam
DYDavid Yeo
David Yeo
MPMarcos Vinicius Perini
Marcos Vinicius Perini
MFMichael A. Fink
Michael A. Fink
VMVijayaragavan Muralidharan
Vijayaragavan Muralidharan
CCChristopher Christophi
Christopher Christophi

1 April 2020 in HPB
Verified
Journal Article
Closed access
GRGeorgina E. Riddiough
Georgina E. Riddiough
CCChristopher Christophi
Christopher Christophi
RJRobert M. Jones
Robert M. Jones
VMVijayaragavan Muralidharan
Vijayaragavan Muralidharan
MPMarcos Vinicius Perini
Marcos Vinicius Perini

1 April 2014 in The American Journal of Surgery
Verified
Journal Article
Closed access
RPRafael S. Pinheiro
Rafael S. Pinheiro
PHPaulo Herman
Paulo Herman
RLRenato M. Lupinacci
Renato M. Lupinacci
QLQuirino Lai
Quirino Lai
EMEvandro S. Mello
Evandro S. Mello
LDLuiz Carneiro D'ALbuquerque
Luiz Carneiro D'ALbuquerque

27 July 2019 in World Journal of Hepatology
Verified
Journal Article
Open access
PHPenelope Hey
Penelope Hey
THTimothy P Hanrahan
Timothy P Hanrahan
MSMarie Sinclair
Marie Sinclair
ATAdam G Testro
Adam G Testro
PAPeter W Angus
Peter W Angus
PGPaul Gow
Paul Gow
Acute liver failure (ALF) is a life-threatening syndrome with varying aetiologies requiring complex care and multidisciplinary management. Its changing incidence, aetiology and outcomes over the last 16 years in the Australian context remain uncertain. To describe the changing incidence, aetiology and outcomes of ALF in South Eastern Australia. The database of the Victorian Liver Transplant Unit was interrogated to identify all cases of ALF in adults (> 16 years) in adults hospitalised between January 2002 and December 2017. Overall, 169 patients meeting criteria for ALF were identified. Demographics, aetiology of ALF, rates of transplantation and outcomes were collected for all patients. Transplant free survival and overall survival (OS) were assessed based on survival to discharge from hospital. Results were compared to data from a historical cohort from the same unit from 1988-2001. Paracetamol was the most common aetiology of acute liver failure, accounting for 50% of cases, with an increased incidence compared with the historical cohort (P = 0.046). Viral hepatitis and non-paracetamol drug or toxin induced liver injury accounted for 15% and 10% of cases respectively. Transplant free survival (TFS) improved significantly compared to the historical cohort (52% vs 38%, P = 0.032). TFS was highest in paracetamol toxicity with spontaneous recovery in 72% of cases compared to 31% of non-paracetamol ALF (P < 0.001). Fifty-nine patients were waitlisted for emergency liver transplantation. Nine of these died while waiting for an organ to become available. Forty-two patients (25%) underwent emergency liver transplantation with a 1, 3 and 5 year survival of 81%, 78% and 72% respectively. Paracetamol toxicity is the most common aetiology of ALF in South-Eastern Australia with a rising incidence over 30 years. TFS has improved, however it remains low in non-paracetamol ALF.